Tissue Resident Memory T Cell Signatures and 22-gene risk model. (IMAGE)

Terasaki Institute for Biomedical Innovation

Tissue Resident Memory T Cell Signatures and 22-gene risk model.

Caption

An extensive analytical study conducted at the Terasaki Institute for Biomedical Innovation (TIBI) has revealed an association between favorable survival outcomes for melanoma patients and the presence of higher populations of tissue-resident memory T cells (TRM).

Credit

iScience

Usage Restrictions

Request permission from iScience

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.